Exclusive

Publication

Byline

Location

US Patent Issued to Evaxion Biotech on April 21 for "Vaccines targeting Pseudomonas aeruginosa" (Danish Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,597, issued on April 21, was assigned to Evaxion Biotech A/S (Horsholm, Denmark). "Vaccines targeting Pseudomonas aeruginosa" was invented... Read More


US Patent Issued to Bactoclear Holdings on April 21 for "Chimeric klebicins" (Indian Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,598, issued on April 21, was assigned to Bactoclear Holdings PTE Ltd. (Singapore). "Chimeric klebicins" was invented by Anisha Ambady (Ban... Read More


US Patent Issued to DANISCO US on April 21 for "Over-expression of GDS1 in yeast for increased ethanol and decreased acetate production" (California, Pennsylvania, Delaware Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,599, issued on April 21, was assigned to DANISCO US INC. (Palo Alto, Calif.). "Over-expression of GDS1 in yeast for increased ethanol and ... Read More


US Patent Issued to Donald Danforth Plant Science Center on April 21 for "Antimicrobial NCR2 peptides" (Missouri Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,600, issued on April 21, was assigned to Donald Danforth Plant Science Center (St. Louis). "Antimicrobial NCR2 peptides" was invented by D... Read More


US Patent Issued to Petroleo Brasileiro S.A.-Petrobras, Universidade Federal Do Ceara-UFC on April 21 for "Genetically modified microorganisms that carry out the heterologous production of modified versions of the surfactant protein LV-ranaspumin-1(LV-RSN-1), the modified versions of said surfactant protein, the synthetic genes encoding said surfactant protein, the expression cassettes containing said synthetic genes, and the expression vectors containing said synthetic genes" (Brazilian Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,601, issued on April 21, was assigned to Petroleo Brasileiro S.A.-Petrobras (Rio de Janeiro, Brazil) and Universidade Federal Do Ceara-UFC ... Read More


US Patent Issued to OSLO UNIVERSITETSSYKEHUS HF on April 21 for "Recombinant CCN domain proteins and fusion proteins" (Norwegian Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,602, issued on April 21, was assigned to OSLO UNIVERSITETSSYKEHUS HF (Nydalen, Norway). "Recombinant CCN domain proteins and fusion protei... Read More


US Patent Issued to Seattle Children's Hospital on April 21 for "IL-13 receptor alpha 2 targeted, zetakine directed T cell immunotherapy" (Washington Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,603, issued on April 21, was assigned to Seattle Children's Hospital (Seattle). "IL-13 receptor alpha 2 targeted, zetakine directed T cell... Read More


US Patent Issued to Regents of the University of Minnesota on April 21 for "Therapeutic compounds and methods" (Minnesota Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,604, issued on April 21, was assigned to Regents of the University of Minnesota (Minneapolis). "Therapeutic compounds and methods" was inv... Read More


US Patent Issued to AKSTON BIOSCIENCES on April 21 for "Ultra-long acting insulin-Fc fusion proteins and methods of use" (Massachusetts Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,605, issued on April 21, was assigned to AKSTON BIOSCIENCES Corp. (Beverly, Mass.). "Ultra-long acting insulin-Fc fusion proteins and meth... Read More


US Patent Issued to RESTORE VISION on April 21 for "Nucleic acid construct that encodes chimeric rhodopsin" (Japanese Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,606, issued on April 21, was assigned to RESTORE VISION INC. (Tokyo). "Nucleic acid construct that encodes chimeric rhodopsin" was invente... Read More